Home / Markets / News / After a muted Q1, Syngene guides for double-digit top line growth

After a muted Q1, Syngene guides for double-digit top line growth

But ongoing capex and depreciation may weigh on bottom line

Premium

Despite the pressure on revenues in the June quarter, the company reported steady operating performance | Photo: Website of Syngene

Ram Prasad Sahu Mumbai

2 min read Last Updated : Jul 23 2020 | 1:28 AM IST

The Syngene International stock ended 1 per cent lower after the company reported a marginal growth in revenues in the June quarter. The top-line performance was pegged back by the disruption in its operations in April because of the Covid-19 pandemic. However, sales growth led by discovery services was in line with the management’s guidance of flat revenue performance in the June quarter.

The company, which offers contract research services to pharma companies, expects growth to return in the September quarter of FY21.

Despite pressure on revenues in the June quarter, the company reported a steady operating performance. Operating profit margins at

Topics : Syngene International

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in